Clinical trial
A Phase I, Double-Blind, Pilot Study of Oxaloacetate in Myasthenia Gravis
NCT04965987 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I, Double-Blind, Pilot Study of Oxaloacetate in Myasthenia Gravis
- Lead sponsor
- University of Kansas Medical Center
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- August 31, 2025
- Completion date
- December 31, 2026
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.